Answers are grounded in this paper and cite their sources.
Explores hormone resistance outcomes in cases of maternal versus paternal Gsα mutation transmission, suggesting a key maternal role.
While loss-of-function mutations in Gsα are invariably associated with the short stature and brachydactyly of Albright hereditary osteodystrophy (AHO), the association with hormone resistance (to parathyroid hormone and thyrotropin) typical of pseudohypoparathyroidism type Ia (PHP-Ia) is much more variable. Observational studies and DNA polymorphism analysis suggest that maternal transmission of the Gsα mutation may be required for full expression of clinical hormone resistance. To test this hypothesis, we studied transmission of a frameshift mutation in Gsα through three generations of a pedigree affected by AHO and PHP-Ia. While all family members carrying this loss-of-function mutation in one Gsα allele had AHO, neither the presence of the mutation nor the degree of reduction of erythrocyte Gsα bioactivity allowed prediction of phenotype (AHO alone versus AHO and PHP-Ia). Paternal transmission of the mutation (from the patriarch of the first generation to three members of the second generation) was not associated with concurrent PHP-Ia, but maternal transmission (from two women in the second generation to four children in the third generation) was invariably associated with PHP-Ia. No expansion of an upstream short CCG nucleotide repeat region was detected, nor was there evidence of uniparental disomy by polymorphism analysis. This report, the first to document the effects across three generations of both paternal and maternal transmission of a specific Gsα mutation, strongly supports the hypothesis that a maternal factor determines full expression of Gsα dysfunction as PHP-Ia. Am. J. Med. Genet. 77:261–267, 1998.
No takes yet. Share an insight, caveat, or question.
Nakamoto et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: